[go: up one dir, main page]

MX9203460A - Nuevos analogos cc-1065 que tienen dos subunidades cpi. - Google Patents

Nuevos analogos cc-1065 que tienen dos subunidades cpi.

Info

Publication number
MX9203460A
MX9203460A MX9203460A MX9203460A MX9203460A MX 9203460 A MX9203460 A MX 9203460A MX 9203460 A MX9203460 A MX 9203460A MX 9203460 A MX9203460 A MX 9203460A MX 9203460 A MX9203460 A MX 9203460A
Authority
MX
Mexico
Prior art keywords
new analogs
cpi
subunits
cpi subunits
analogs
Prior art date
Application number
MX9203460A
Other languages
English (en)
Inventor
Robert C Kelly
Paul A Aristoff
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Priority claimed from PCT/US1989/003329 external-priority patent/WO1990002746A1/en
Publication of MX9203460A publication Critical patent/MX9203460A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX9203460A 1988-09-12 1989-08-07 Nuevos analogos cc-1065 que tienen dos subunidades cpi. MX9203460A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24335088A 1988-09-12 1988-09-12
PCT/US1989/003329 WO1990002746A1 (en) 1988-09-12 1989-08-07 Novel cc-1065 analogs having two cpi subunits

Publications (1)

Publication Number Publication Date
MX9203460A true MX9203460A (es) 1992-09-01

Family

ID=26779868

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203460A MX9203460A (es) 1988-09-12 1989-08-07 Nuevos analogos cc-1065 que tienen dos subunidades cpi.

Country Status (3)

Country Link
EP (1) EP0359454B1 (es)
ES (1) ES2153814T3 (es)
MX (1) MX9203460A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258383A (en) * 1991-06-28 1993-11-02 Kyowa Hakko Kogyo Co., Ltd. DC-89 derivatives
ES2149768T3 (es) * 1992-03-25 2000-11-16 Immunogen Inc Conjugados de agentes enlazantes de celulas derivados de cc-1065.
US5248691A (en) * 1992-09-03 1993-09-28 Eli Lilly And Company Furanoindolines
ES2074957B1 (es) * 1993-11-19 1996-06-16 Univ Santiago Compostela Nuevos derivados de pirrolo(3,2-e)indol, procedimiento para su preparacion y aplicaciones.
US5786377A (en) * 1993-11-19 1998-07-28 Universidad De Santiago De Compostela Pyrrolo 3,2-E!indol derivatives, process for the preparation thereof and applications
US6924276B2 (en) 2001-09-10 2005-08-02 Warner-Lambert Company Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
JP5203701B2 (ja) * 2004-05-12 2013-06-05 プロテオテック・インコーポレイテッド アミロイド疾患、及びシヌクレイノパチー治療用置換n−アリールベンズアミド、及び関連化合物
MX2011004625A (es) * 2008-11-03 2011-07-20 Syntarga Bv Analogos cc-1065 novedosos y sus conjugados.
PT3069735T (pt) 2014-01-10 2018-05-18 Synthon Biopharmaceuticals Bv Adc de duocarmicina para utilização no tratamento de cancro da bexiga
PT3092010T (pt) 2014-01-10 2018-09-28 Synthon Biopharmaceuticals Bv Método para purificação de conjugados anticorpo-fármaco ligados por cys
PT2948183T (pt) 2014-01-10 2016-07-13 Univ Yale Conjugados anticorpo-fármaco de duocarmicina para utilização no tratamento de cancro do endométrio
WO2015110935A1 (en) * 2014-01-27 2015-07-30 Pfizer Inc. Bifunctional cytotoxic agents
SG11201706991YA (en) 2015-03-20 2017-10-30 Pfizer Bifunctional cytotoxic agents containing the cti pharmacophore

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301248A (en) * 1979-12-21 1981-11-17 Bristol-Myers Company Fermentation process for making rachelmycin
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
WO1988005659A1 (en) * 1987-02-06 1988-08-11 Zymogenetics, Inc. Human proteins having anticoagulant and anti-inflammatory activity

Also Published As

Publication number Publication date
EP0359454A1 (en) 1990-03-21
EP0359454B1 (en) 2000-12-27
ES2153814T3 (es) 2001-03-16

Similar Documents

Publication Publication Date Title
DE68914856D1 (de) Synergetische Antioxydationsmischung.
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
DE68903402D1 (de) Dehnungsmesser.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
IT1215765B (it) Dispositivo di emodiafiltrazione erelativo procedimento di emodiafiltrazione.
MX9203460A (es) Nuevos analogos cc-1065 que tienen dos subunidades cpi.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE68907177D1 (de) Dosierungsform.
FI890488A0 (fi) Vaextextrakt innehaollande farmaceutiska preparat samt foerfarande foer framstaellning daerav.
DE68927202D1 (de) Paralleler Prozessor
DE68921245D1 (de) Flüssige Entwicklerzusammensetzungen.
DE58909062D1 (de) Hochwirksame Polarisatoren.
ATE99694T1 (de) Antiparasitaere derivate.
DE68912004D1 (de) Entwicklungsgerät.
DE69011732D1 (de) Serotonin-Antagonist.
DE68921096D1 (de) Flüssige Entwicklerzusammensetzungen.
ATE102624T1 (de) Makrolide derivate.
DE69009887D1 (de) Bizyklische Derivate.
NO893219D0 (no) Vann-i-olje-sprengstoffemulsjon.
DE68910299D1 (de) Brotaufstrich.
FI905506A0 (fi) Viskoelastisk daempare.
DK331389A (da) Fremgangsmaade til bestemmelse af pyrogenindhold
MX9203632A (es) Derivados de cicloalquiltiazol y composiciones farmaceuticas que los contienen.
FI894072A0 (fi) Polypeptider anvaendbara som vaccin.
DE68915937D1 (de) Reduzierung von prozessorblockierungseffekten.